Related Experiment Videos
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1).
European journal of cancer (Oxford, England : 1990)·2018
CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2005
Serum tumor marker CA 125 for monitoring ovarian cancer during follow-up.
Scandinavian journal of clinical and laboratory investigation·2002
Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy.
British journal of cancer·2001
Biological variation and analytical imprecision of CA 125 in patients with ovarian cancer.
Scandinavian journal of clinical and laboratory investigation·2001
[Suture lateralisation of the vocal fold in a patient with bilateral vocal cord paralysis].
Ugeskrift for laeger·2026
[Transcranial magnetic stimulation in non-psychiatric disorders].
Ugeskrift for laeger·2026
[Coronary artery calcium and cardiovascular prevention].
Ugeskrift for laeger·2026
[Advanced therapy medicinal products].
Ugeskrift for laeger·2026
[Giant panniculectomy].
Ugeskrift for laeger·2026
Treatment patterns, access, and multidimensional burden of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in China: A nationwide cross-sectional study.
Therapeutic advances in neurological disorders·2026
Efficacy and safety of interleukin-6 receptor inhibitors in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic review and meta-analysis.
Therapeutic advances in neurological disorders·2026
Netrin-1 suppresses CCL2-driven macrophage migration: implications for modulating vascular inflammation and aortic sinus enlargement in hyperlipidaemic mice.
Journal of molecular and cellular cardiology plus·2026